Atai shares pop after earnings: Company's CEO talks about mental health and psychedelics

Atai Life Sciences, a biopharmaceutical and psychedelic company reported its first earnings since going public in June. Florian Brand, Atai's CEO and co-founder joins Closing Bell to discuss the future of his company and bringing its product to market.
Mon, Aug 16 20213:57 PM EDT